- Isacson J, Trollfors B, Taranger J, Zackrisson G, Lagergård T. How common is whooping cough in a nonvaccinating country? Pediatr Infect Dis J 1993; 12: 284–8.
- Heininger U, Klemens S, Schmitt-Grohe S, Lorenz C, Rost R, Christenson P, et al. Clinical characteristics of Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994; 13: 306–9.
- Mastrantonio P, Stefanelli P, Giuliano M, Herrera Rojas Y, Ciofi degli Atti M, et al. Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates. J Clin Microbiol 1998; 36: 999–1002.
- Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular and a whole-cell pertussis vaccine. N Engl J Med 1996; 334: 349–55.
- Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. Efficacy trial of acellular pertussis vaccine. Technical Report, Trial I. SMI-tryck 1995; 105: 1–70.
- Saikku P. Atypical respiratory pathogens. Clin Microbiol Infect 1997; 3: 599–604.
- McGregor K, Chang BJ, Mee BJ, Riley TV. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases. Eur J Clin Microbiol Infect Dis 1998; 17: 219–34.
- Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993; 17 (Suppl 1): S37–46.
- Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. Erythromycin ethylsuccinate. Pediatr Infect Dis 1995; 14: 471–7.
- Hallander HO, Reizenstein E, Renemar B, Rasmuson G, Mardin L, Olin P. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J Clin Microbiol 1993; 31: 50–2.
- Regan J and Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol 1977; 6: 303–9.
- Reizenstein E, Hallander HO, Blackwelder WC, Kuhn I, Ljungman M, Möllby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods 1995; 183: 279–90.
- Gnarpe J, Eriksson K. Sample preparation for Chlamydia pneumoniae PCR. APMIS 1995; 103: 307–8.
- Tong CYW, Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 1993; 46: 313–7.
- Bernet C, Garret M, de Barbeyrac B, Bebear C, Bonnet J. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J Clin Microbiol 1989; 27: 2492–6.
- von König CHW, Rott H, Bogaerts H, Schmitt HJ. A serological study of organisms possbly associated with pertussis-like coughing. Pediatr Infect Dis J 1998; 17: 645–9.
- Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet 1997; 350: 1569–77.
- Lund-Olsen I, Lundbäck A, Gnarpe J, Gnarpe H. Prevalence of specific antibodies to Chlamydia pneumoniae in children with acute respiratory infections. Acta Pediatr 1994; 83: 1143–5.
- Grayston JT. Chlamydia pneumoniae (TWAR) infections in children. Pediatr Inf Dis J 1994; 13: 675–5.
- Normann E, Gnarpe J, Gnarpe H, Wettergren B. Chlamydia pneumoniae in children with acute respiratory tract infections. Acta Paediatr 1998; 87: 23–7.
- Normann E, Gnarpe J, Gnarpe H, Wettergren B. Chlamydia pneumoniae in children attending day-care centers in Gävle, Sweden. Pediatr Infect Dis J 1998; 17: 474–8.
- Falck G, Gnarpe J, Gnarpe H. Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections. Pediatr Infect Dis J 1997; 16: 549–54.
- Gnarpe J, Gnarpe H, Sundelöf B. Endemic prevalence of Chlamydia pneumoniae in subjectively healthy persons. Scand J Infect Dis 1991; 23: 387–8.
- Gnarpe J, Lundbäck A, Sundelöf B, Gnarpe H. Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis 1992; 24: 161–4.
- WHO meeting on case definition of pertussis: Geneva, 10–11 January 1991. Geneva: World Health Organization, 1991: 4–5 (Issue no. MIN/EPI/PERT/91.1.
- Stehr K, Cherry JD, Heininger U, Schmitt-Grohe’ S, Uberall M, Laussucq S, et al. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DtaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 1998; 101: 1–11.
- Trollfors B, Taranger J, Lagergård T. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 1995; 333: 1045–50.
Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and Persistent Cough in Children
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.